Gene amplification in MYCN is the first genetic marker that indicates a highly invasive, advanced neuroblastoma, which has been observed in about 20% of primary and about 40% of high-risk neuroblastoma cases [44]. The gene discussed is MYCN; the disease is neuroblastoma.